Duquesne Family Office LLC / VKTX
Duquesne Family Office LLC’s Viking Therapeutics Inc Position
Does Duquesne Family Office LLC own Viking Therapeutics Inc (VKTX)? Not currently — the last reported position was 549.3K shares worth $15M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$15M
Q2 2025
Shares
549.3K
% of Portfolio
+0.36%
Quarters Held
1
position exited
Position History VKTX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2025 | 549.3K | $15M | +0.36% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Duquesne Family Office LLC’s full portfolio or all institutional holders of VKTX.